PLoS One-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-09-19 ms7000000051867986

偏重的研究方向：骨科
经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-07-18 145d8f61m85暂无昵称

各位大佬，这个杂志官网是不是没有稿件的Word模板

84 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-04-17 ms6502024518793471

小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人
manuscript submitted to journal 2.21
with editor 2.28
under review 2.29
decision in process 3.16
revise-minor reversion 3.17
manuscript submitted to journal 3.19
with editor 3.20
decision in process 3.20
submissions in production 3.24
论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020
我就是想问期刊什么时候收我稿费啊，之后怎么没动静了

278 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-08-20 lulilan2011

审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-07-01 ms2000001076054986

这杂志最近对纯生信非常友好

104 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-07-25 ms9000001281919793

审稿速度:2.0 | 投稿命中率:75.0
经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？
If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-06-28 1de1d863m71(暂无匿称)

偏重的研究方向：肿瘤
经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下

76 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-06-24 ms20000019

投稿命中率:75.0
经验分享：这个现在如何？

113 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-05-05 zhanyu

plos one在国内名气好吗？认可吗？

250 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2089137, encodeId=6ee0208913ecc, content=偏重的研究方向：骨科 经验分享：有没有大神知道关于手稿中的图片并非基础类文章也要单独上传吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28388132510, createdName=ms7000000051867986, createdTime=Mon Sep 19 23:47:04 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233251, encodeId=5fd2123325195, content=各位大佬，这个杂志官网是不是没有稿件的Word模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0715092981, createdName=145d8f61m85暂无昵称, createdTime=Mon Jul 18 19:35:44 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859546, encodeId=ce8e8595466c, content=小硕的第一篇sci，这个期刊还是蛮快的，开心继续努力，这个审稿快慢一直没搞清原因，总之比别人周期快很多，也没有推荐审稿人 manuscript submitted to journal 2.21 with editor 2.28 under review 2.29 decision in process 3.16 revise-minor reversion 3.17 manuscript submitted to journal 3.19 with editor 3.20 decision in process 3.20 submissions in production 3.24 论文稿件显示结果：received: february 21, 2020；accepted: march 20, 2020；published: april 15, 2020 我就是想问期刊什么时候收我稿费啊，之后怎么没动静了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Fri Apr 17 17:13:19 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239978, encodeId=180212399e86f, content=审稿还是很严的，以前我写不怎么样，被拒稿多次，后来新的文章写好了，修了很多次才接收。不是交费的期刊都烂，很多1区都缴费呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e941214, createdName=lulilan2011, createdTime=Sat Aug 20 13:03:41 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229938, encodeId=6e13122993897, content=这杂志最近对纯生信非常友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Fri Jul 01 14:04:59 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234642, encodeId=5bef123464272, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：大神们，第一次投SCI想请教一下数据可用性声明更改后是不是“最小数据集”可以不公开？ If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0458249443, createdName=ms9000001281919793, createdTime=Mon Jul 25 17:10:16 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229183, encodeId=132b12291832a, content=偏重的研究方向：肿瘤 经验分享：plos one官网论文已经可以看到了，pubmed查不到是什么情况，多久可以查到！哪位前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ea51674777, createdName=1de1d863m71(暂无匿称), createdTime=Tue Jun 28 15:45:53 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799625, encodeId=f9dee996254b, content=投稿命中率:75.0 经验分享：这个现在如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220109/a91135a444374d4f8e4806c5f642b48d/00bdaaa0fa3a4c3f88477c67e48d15d1.jpg, createdBy=b0b45296453, createdName=ms20000019, createdTime=Wed Jun 24 23:12:03 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590270, encodeId=7aba5902e0c5, content=plos one在国内名气好吗？认可吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860538, encodeId=491286053891, content=2019年9月录用，今年5月还没有检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu May 14 09:48:05 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-05-14 ms4573613856522007

2019年9月录用，今年5月还没有检索

0 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务